金域医学 (603882)
Guangzhou Kingmed Diagnostics Group Co., Ltd.
K-Line Chart
No K-line data available
Company NameGuangzhou KingMed Diagnostics Group Co., Ltd.
Listing Date2017-09-08
Issue Price6.93RMB
Registered Capital46325.827510k RMB
Legal RepresentativeLiang Yaoming
Registered AddressNo. 10, Luoxuan 3rd Road, Guangzhou International Bio-Island, Guangdong Province, China
IndustryMedical Services
Main BusinessA medical diagnostic information integration service provider centered on third-party medical testing and pathology diagnosis outsourcing services.
Company Profile 广州金域医学检验集团股份有限公司【股票代码:603882】是一家以第三方医学检验及病理诊断业务为核心的高科技服务企业,通过不断积累的“大平台、大网络、大服务、大样本和大数据”等核心资源优势,致力于为全国各级医疗机构提供领先的医学诊断信息整合服务。金域医学的核心创业团队自上世纪90年代即积极探索医学检验外包服务在中国的运营模式,开创了国内第三方医学检验行业的先河,经过多年的发展,现已成为国内第三方医学检验行业的市场领先企业。
Stock Details
1. Key Indicators
- Total Shares(W): 46325.83
- Circulating A-Shares(W): 46013.46
- Earnings Per Share(RMB): -0.1700
- Net Assets Per Share(RMB): 14.7400
- Operating Revenue(W RMB): 453815.14
- Total Profit(W RMB): -8211.78
- **Net Profit Attributable to Parent(W RMB) **: -7960.95
- Net Profit Growth Rate(%): -184.84
- Weighted Return on Equity(%): -1.1400
- Operating Cash Flow Per Share(RMB): 1.4500
- Undistributed Profit Per Share(RMB): 10.6477
- Capital Reserve Per Share(RMB): 2.5248
2. Main Business
The main business covers:
- Providing medical testing and pathological diagnosis outsourcing services to various medical institutions (including hospitals, maternal and child health hospitals, health centers, etc.)
3. Company Basic Information
- Company Name: Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Listing Date: 2017-09-08
- Industry: Healthcare
- Address: No. 10, Spiral 3rd Road, Guangzhou International Bio-Island, Guangdong Province
- Website: https://www.kingmed.com.cn/
- Company Profile: The company was established by Liang Yaoming and 11 other shareholders as promoters through the overall transformation of Kingmed Limited into a joint stock company. On June 11, 2015, Kingmed Limited held a shareholders' meeting and resolved to convert the company's audited net assets of 323.5534 million yuan as of March 31, 2015 into 190 million shares of the joint stock company at a ratio of 1:0.587229. The portion of net assets exceeding the registered capital, 133.5534 million yuan, was used as the capital reserve of the joint stock company. The capital contributions of the 12 promoter shareholders during this transformation were verified by Lixin Certified Public Accountants on July 15, 2015, and the business license was issued by Guangzhou Administration for Industry and Commerce on July 24, 2015.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 3550.57 | 7.72 |
| 2 | Guochuang Kaiyuan Equity Investment Fund (Limited Partnership) | General Legal Person | 3088.09 | 6.71 |
| 3 | Guangzhou Xinmanyu Investment Consulting Partnership (Limited Partnership) | General Legal Person | 2859.01 | 6.21 |
| 4 | Guangzhou Shengyufang Investment Consulting Partnership (Limited Partnership) | General Legal Person | 2100.00 | 4.56 |
| 5 | Guangzhou Shengboyu Investment Consulting Partnership (Limited Partnership) | General Legal Person | 1929.88 | 4.19 |
| 6 | Guangzhou Ruizhi Investment Consulting Partnership (Limited Partnership) | General Legal Person | 1490.29 | 3.24 |
| 7 | Huabao CSI Medical ETF | Fund | 787.86 | 1.71 |
| 8 | China Foreign Economic and Trade Trust Co., Ltd. - Foreign Trade Trust - Renqiao Zeyuan Stock Private Securities Investment Fund | Private Securities Investment Fund | 586.42 | 1.27 |
| 9 | Ruizhong Life Insurance Co., Ltd. - Own Funds | Insurance | 522.17 | 1.13 |
| 10 | Great Wall Consumption Growth Mixed Securities Investment Fund Class A | Fund | 130.05 | 0.28 |
5. Concept Sectors
- Intelligent Machines
- Gene Concept
- Immunotherapy
- Artificial Intelligence
- Tencent Concept
- Cold Chain Logistics
- Helicobacter Pylori
- Hepatitis Concept
- AIGC Concept
- Data Elements
- AI Agents
- DeepSeek
- AI Healthcare
- Margin Trading
- Consecutive Losses
- Heavy Northbound Holdings
- New Private Placements
- Guozheng Services
Remarks
- Data update date: 2025-11-07
- Data source: Public market information